FLJ31945: A Potential Drug Target and Biomarker (G440137)

Target Name: FLJ31945

NCBI ID: G440137

FLJ31945

Other Name(s): Uncharacterized LOC440137

FLJ31945: A Potential Drug Target and Biomarker

FLJ31945 is a protein that is expressed in various tissues of the human body, including the brain, heart, and liver. Its function is not well understood, but it is known to play a role in the regulation of cell signaling pathways, which are critical for many cellular processes, including growth, differentiation, and survival.

One of the interesting aspects of FLJ31945 is its potential as a drug target. The FLJ31945 gene has been shown to be involved in the regulation of several key signaling pathways, including the TGF-β pathway, which is involved in cell signaling and growth, and the NF-kappa-B pathway, which is involved in inflammation and stress responses.

Additionally, FLJ31945 has been shown to play a role in the regulation of cellular processes that are related to disease, such as the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

The identification of FLJ31945 as a potential drug target is an exciting development in the field of neurodegenerative diseases, as it provides a new target for researchers to explore in order to develop new treatments for these debilitating diseases.

FLJ31945 is also a potential biomarker for several neurodegenerative diseases. The expression of FLJ31945 has been shown to be reduced in the brains of individuals with Alzheimer's disease and Parkinson's disease, which suggests that it may be a useful biomarker for these diseases. Additionally, the levels of FLJ31945 have been shown to be elevated in the urine and plasma of individuals with Parkinson's disease, which could be used as a potential diagnostic biomarker.

In conclusion, FLJ31945 is a protein that has the potential to be a drug target for neurodegenerative diseases. Its function in the regulation of cell signaling pathways and its expression in various tissues make it an attractive target for researchers to explore. Additionally, its potential as a biomarker for neurodegenerative diseases makes it an important molecule to study further. Further research is needed to fully understand the role of FLJ31945 in neurodegenerative diseases and to develop new treatments.

Protein Name: Uncharacterized LOC440137

The "FLJ31945 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ31945 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets